 |
|
|
|
 |
|
Influenza A Virus Lacking M2 Protein as a Live Attenuated Vaccine
Watanabe S, Watanabe T, Kawaoka Y.
J Virol. 2009 Jun;83(11):5947-50. Epub 2009 Mar 25. (Abstract, Full Text, PDF) |
|
Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge
Perrone LA, Ahmad A, Veguilla V, Lu X, Smith G, Katz JM, Pushko P, Tumpey TM.
J Virol. 2009 Jun;83(11):5726-34. Epub 2009 Mar 25. (Abstract, Full Text, PDF) |
|
Identification of 2-aminothiazole-4-carboxylate derivatives active against Mycobacterium tuberculosis H37Rv and the beta-ketoacyl-ACP synthase mtFabH.
Al-Balas Q, Anthony NG, Al-Jaidi B, Alnimr A, Abbott G, Brown AK, Taylor RC, Besra GS, McHugh TD, Gillespie SH, Johnston BF, Mackay SP, Coxon GD.
PLoS ONE. 2009;4(5):e5617. Epub 2009 May 19. (Abstract, Full Text, PDF) |
|
Molecular Detection of a Novel Human Influenza (H1N1) of Pandemic Potential by Conventional and Real-Time Quantitative RT-PCR Assays.
Poon LL, Chan KH, Smith GJ, Leung CS, Guan Y, Yuen KY, Peiris JS.
Clin Chem. 2009 May 13. [Epub ahead of print] (Abstract, PDF)
|
|
Swine flue outbreak. Flu researchers train sights on novel tricks of novel H1N1.
Cohen J.
Science. 2009 May 15;324(5929):870-1. (Full Text)
|
|
Rapid subtyping of H9N2 influenza virus by a triple reverse transcription polymerase chain reaction.
Chen HT, Zhang J, Ma LN, Ma YP, Ding YZ, Wang M, Liu XT, Zhang YG, Liu YS.
J Virol Methods. 2009 Jun;158(1-2):58-62. Epub 2009 Feb 6. (Abstract)
|
|
Development of a novel real-time reverse-transcriptase PCR method for the detection of H275Y positive influenza A H1N1 isolates.
Bolotin S, Robertson AV, Eshaghi A, De Lima C, Lombos E, Chong-King E, Burton L, Mazzulli T, Drews SJ.
J Virol Methods. 2009 Jun;158(1-2):190-4. Epub 2009 Jan 30. (Abstract)
|
|
Pandemic Potential of a Strain of Influenza A (H1N1) : Early Findings.
Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, Jombart T, Hinsley WR, Grassly NC, Balloux F, Ghani AC, Ferguson NM, Rambaut A, Pybus OG, Lopez-Gatell H, Apluche-Aranda CM, Chapela IB, Zavala EP, Guevara DM, Checchi F, Garcia E, Hugonnet S, Roth C; The WHO Rapid Pandemic Assessment Collaboration.
Science. 2009 May 11. [Epub ahead of print] (Abstract, PDF)
|
|
Swine influenza.
Kerr JR.
J Clin Pathol. 2009 May 10. [Epub ahead of print] (Abstract)
|
|
H1N1 Influenza A Disease — Information for Health Professionals
Baden LR, Drazen JM, Kritek PA, Curfman GD, Morrissey S, Campion EW.
N Engl J Med. 2009 May 7. [Epub ahead of print] (Full Text, PDF)
|
|
Implications of the Emergence of a Novel H1 Influenza Virus.
Belshe RB.
N Engl J Med. 2009 May 7. [Epub ahead of print] (Full Text, PDF)
|
|
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans.
Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team.
N Engl J Med. 2009 May 7. [Epub ahead of print] (Abstract, Full Text, PDF)
|
|
Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005-2009.
Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, Lindstrom S, Gubareva LV, Deyde V, Garten RJ, Harris M, Gerber S, Vagoski S, Smith F, Pascoe N, Martin K, Dufficy D, Ritger K, Conover C, Quinlisk P, Klimov A, Bresee JS, Finelli L.
N Engl J Med. 2009 May 7. [Epub ahead of print] (Abstract, Full Text, PDF)
|
|
Digital Disease Detection -- Harnessing the Web for Public Health Surveillance.
Brownstein JS, Freifeld CC, Madoff LC.
N Engl J Med. 2009 May 7. [Epub ahead of print] (Full Text, PDF)
|
|
The Signature Features of Influenza Pandemics -- Implications for Policy.
Miller MA, Viboud C, Balinska M, Simonsen L.
N Engl J Med. 2009 May 7. [Epub ahead of print] (Full Text, PDF)
|
|
Influenza virus shedding: excretion patterns and effects of antiviral treatment.
Aoki FY, Boivin G.
J Clin Virol. 2009 Apr;44(4):255-61. Epub 2009 Mar 9. (Review: No Abstract Available)
(22/4/2552)
Source: http://www.journalofclinicalvirology.com/article/S1386-6532(09)00044-4/abstract |
|
A simple method for evaluating dengue vaccine effectiveness in mice based on levels of viremia caused by intraperitoneal injection of infected culture cells
Atsushi Y., Eiji K.
Vaccine. 2009 (In Press)
(Abstract)
(22/4/2552)
|
|
Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza
Steel J, Lowen AC, Pena L, Angel M, Solórzano A, Albrecht R, Perez DR, García-Sastre A, Palese P.
J Virol. 2009 Feb;83(4):1742-53. Epub 2008 Dec 10.
(Abstract)
(4/2/2552) |
|
Novel Influenza Virus NS1 Antagonists Block Replication and Restore Innate Immune Function
Basu D, Walkiewicz MP, Frieman M, Baric RS, Auble DT, Engel DA.
J Virol. 2009 Feb;83(4):1881-91. Epub 2008 Dec 3.
(Abstract)
(4/2/2552) |
|
Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity.
McArthur JH, Durbin AP, Marron JA, Wanionek KA, Thumar B, Pierro DJ, Schmidt AC, Blaney JE Jr, Murphy BR, Whitehead SS.
Am J Trop Med Hyg. 2008 Nov;79(5):678-84.
(Abstract)
(1/12/2551) |
|
Growth Determinants for H5N1 Influenza Vaccine Seed Viruses in MDCK Cell
Murakami S, Horimoto T, Mai le Q, Nidom CA, Chen H, Muramoto Y, Yamada S, Iwasa A, Iwatsuki-Horimoto K, Shimojima M, Iwata A, Kawaoka Y.
J Virol. 2008 Nov;82(21):10502-9. Epub 2008 Sep 3.
(Abstract)
(20/11/2551) |
|
A dry-format field-deployable quantitative reverse transcriptase-polymerase chain reaction assay for diagnosis of dengue infections.
Wu SJ, Pal S, Ekanayake S, Greenwald D, Lara S, Raviprakash K, Kochel T, Porter K, Hayes C, Nelson W, Callahan J.
Am J Trop Med Hyg. 2008 Oct;79(4):505-10.
(Abstract)
(17/11/2551) |
|
Evaluation of a rapid diagnostic test specific for Plasmodium vivax.
Kim SH, Nam MH, Roh KH, Park HC, Nam DH, Park GH, Han ET, Klein TA, Lim CS.
Trop Med Int Health. 2008 Dec;13(12):1495-500. Epub 2008 Oct 6.
(Abstract)
(17/11/2551) |
|
Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates.
Bernardo L, Izquierdo A, Alvarez M, Rosario D, Prado I, López C, Martínez R, Castro J, Santana E, Hermida L, Guillen G, Guzmán MG.
Antiviral Res. 2008 Nov;80(2):194-9. Epub 2008 Jul 3.
(Abstract)
(10/11/2551) |
|
Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction.
Junjhon J, Lausumpao M, Supasa S, Noisakran S, Songjaeng A, Saraithong P, Chaichoun K, Utaipat U, Keelapang P, Kanjanahaluethai A, Puttikhunt C, Kasinrerk W, Malasit P, Sittisombut N.
J Virol. 2008 Nov;82(21):10776-91. Epub 2008 Aug 20.
(Abstract)
(29/10/2551) |
|
Association of dengue virus NS1 protein with lipid rafts.
Noisakran S, Dechtawewat T, Avirutnan P, Kinoshita T, Siripanyaphinyo U, Puttikhunt C, Kasinrerk W, Malasit P, Sittisombut N.
J Gen Virol. 2008 Oct;89(Pt 10):2492-500.
(Abstract)
(24/10/2551) |
|
H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
Mahmood K, Bright RA, Mytle N, Carter DM, Crevar CJ, Achenbach JE, Heaton PM, Tumpey TM, Ross TM.
Vaccine. 2008 Oct 3;26(42):5393-9. Epub 2008 Aug 14.
(Abstract)
(28/10/2551) |
|
DNA fusion vaccines incorporating IL-23 or RANTES for use in immunization against influenza.
Williman J, Young S, Buchan G, Slobbe L, Wilson M, Pang P, Austyn J, Preston S, Baird M.
Vaccine. 2008 Sep 19;26(40):5153-8. Epub 2008 Apr 18.
(Abstract)
(28/10/2551) |
|
An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines.
Hickman D, Hossain MJ, Song H, Araya Y, Solórzano A, Perez DR.
J Gen Virol. 2008 Nov;89(Pt 11):2682-90.
(Abstract)
(28/10/2551) |
| |
|
|
| |
|
|
| |
|
